{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:19:10Z","timestamp":1791379150382,"version":"4.3.2"},"reference-count":0,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T00:00:00Z","timestamp":1060646400000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc electrophysiol"],"published-print":{"date-parts":[[2002,10]]},"abstract":" Biventricular Pacing.<\/jats:bold>\n Introduction<\/jats:italic>: The aim of this study is to describe implantation techniques and lead performance for biventricular pacing, dual\u2010chamber implantable cardioverter defibrillators (ICDs).<\/jats:p> Methods and Results<\/jats:italic>: A dual\u2010chamber ICD with biventricular pacing was implanted in 87 patients with congestive heart failure (ejection fraction: 0.21 \u00b1 0.09<\/jats:styled-content>), prolonged QRS duration (161 \u00b1 22 msec<\/jats:styled-content>), and an indication for ICD therapy. Left ventricular pacing was achieved with a thoracotomy approach (n = 21<\/jats:styled-content>) or a nonthoracotomy approach (n = 66<\/jats:styled-content>). With a thoracotomy, biventricular devices were implanted successfully in all patients. During follow\u2010up (17 \u00b1 11 months<\/jats:styled-content>), 9 patients died (43%), 2 underwent transplantation, and 2 required left ventricular lead revision. At last follow\u2010up, biventricular sensing and capture threshold were 11 \u00b1 5 mV and 1.5 \u00b1 0.8 V,<\/jats:styled-content> respectively. For nonthoracotomy procedures, two types of coronary sinus (CS) leads were implanted: an over\u2010the\u2010wire lead (n = 45<\/jats:styled-content>) and a shaped lead (n = 21<\/jats:styled-content>). The rate of successful implantation (overall: 89%) (over\u2010the\u2010wire 93% vs shaped 81%; P = 0.1<\/jats:styled-content>) and durations for CS lead placement (66 \u00b1 50 vs 58 \u00b1 34 min, P = 0.6<\/jats:styled-content>) and the procedure (133 \u00b1 58 vs 129 \u00b1 33 min, P = 0.8<\/jats:styled-content>) were not different between the two CS leads. During follow\u2010up (11 \u00b1 9 months<\/jats:styled-content>), 9 patients died (14%), and the shaped CS lead dislodged in 3 patients (3 shaped vs 0 over\u2010the\u2010wire, P = 0.01<\/jats:styled-content>). At last follow\u2010up, biventricular sensing and capture threshold were 10 \u00b1 4 mV and 1.8 \u00b1 0.7 V<\/jats:styled-content>, respectively, and there was no difference between over\u2010the\u2010wire and shaped leads. By multivariate analysis, mortality was associated with absence of spironolactone therapy but not procedural features.<\/jats:p> Conclusion<\/jats:italic>: Nonthoracotomy CS lead implantation is feasible, with a success rate of about 90% and few adverse events. For the remaining 10%, a thoracotomy approach can be completed safely in these ill patients without increased risk for death.<\/jats:p>","DOI":"10.1046\/j.1540-8167.2002.00964.x","type":"journal-article","created":{"date-parts":[[2004,12,26]],"date-time":"2004-12-26T20:17:50Z","timestamp":1104092270000},"page":"964-970","source":"Crossref","is-referenced-by-count":80,"title":["Implantation Techniques and Chronic Lead Parameters of Biventricular Pacing Dual\u2010Chamber Defibrillators"],"prefix":"10.1111","volume":"13","author":[{"given":"EMILE G.","family":"DAOUD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEVEN J.","family":"KALBFLEISCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN D.","family":"HUMMEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAUL","family":"WEISS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RALPH S.","family":"AUGUSTINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEVEN B.","family":"DUFF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GEORGIA","family":"POLSINELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"CASTOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TEJAS","family":"META","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,8,12]]},"container-title":["Journal of Cardiovascular Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1540-8167.2002.00964.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1540-8167.2002.00964.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:36:25Z","timestamp":1700267785000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1540-8167.2002.00964.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1046\/j.1540-8167.2002.00964.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1540-8167.2002.00964.x","archive":["Portico"],"relation":{},"ISSN":["1045-3873","1540-8167"],"issn-type":[{"value":"1045-3873","type":"print"},{"value":"1540-8167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}